Showing results (611-620 of 694) with videos related to

Sort By:
Pageof 70
The American Surgeon|April 1, 1996
Outcomes analysis for 50 liver transplant recipients: the Vanderbilt experienceJ L Payne, K R McCarty, J G Drougas, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2018
ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate CancerJ Athene Lane, Vanessa Er, Kerry N L Avery, et al.
Nature Communications|March 25, 2026
CD8<sup>+</sup> T cells sustain vaccination-induced immunity against dissemination of contained tuberculosis in immunosuppressed hostsSocorro Miranda-Hernandez, Manoharan Kumar, Alec Henderson, et al.
Pharmacotherapy|May 8, 2019
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical TrialC Lindsay DeVane, Jane M Charles, Ruth K Abramson, et al.
OTA International : the Open Access Journal of Orthopaedic Trauma|August 8, 2024
Rehabilitation after musculoskeletal injury: European perspectiveMichael Kelly, Richard L Donovan, Zoe H Dailiana, et al.
Nature|November 3, 2006
Inactivation of the p53 pathway in retinoblastomaNikia A Laurie, Stacy L Donovan, Chie-Schin Shih, et al.
Health Technology Assessment (Winchester, England)|September 29, 2018
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCTFreddie C Hamdy, Daisy Elliott, Steffi le Conte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
Pageof 70